Analysen von Emmanuel Papadakis

20.05.20 AstraZeneca overweight Barclays Capital
15.05.20 Roche kaufen Barclays Capital
07.05.20 Novo Nordisk overweight Barclays Capital
01.05.20 AstraZeneca overweight Barclays Capital
09.04.20 Bayer overweight Barclays Capital
09.04.20 AstraZeneca overweight Barclays Capital
09.04.20 Novo Nordisk overweight Barclays Capital
09.04.20 Roche overweight Barclays Capital
03.04.20 Roche overweight Barclays Capital
24.03.20 Bayer overweight Barclays Capital
17.03.20 Roche overweight Barclays Capital
17.03.20 Novo Nordisk overweight Barclays Capital
17.03.20 AstraZeneca overweight Barclays Capital
17.03.20 Bayer overweight Barclays Capital
02.03.20 Novo Nordisk overweight Barclays Capital
27.02.20 Bayer overweight Barclays Capital
20.02.20 Roche overweight Barclays Capital
19.02.20 Bayer overweight Barclays Capital
18.02.20 AstraZeneca overweight Barclays Capital
06.02.20 Novo Nordisk overweight Barclays Capital
05.02.20 Novo Nordisk overweight Barclays Capital
31.01.20 Novo Nordisk overweight Barclays Capital
30.01.20 Roche overweight Barclays Capital
20.01.20 Bayer overweight Barclays Capital
17.01.20 Novo Nordisk overweight Barclays Capital
16.01.20 Novo Nordisk overweight Barclays Capital
16.01.20 Roche overweight Barclays Capital
16.01.20 AstraZeneca overweight Barclays Capital
16.01.20 Bayer overweight Barclays Capital
02.12.19 Roche overweight Barclays Capital
22.11.19 AstraZeneca overweight Barclays Capital
18.11.19 Novo Nordisk overweight Barclays Capital
25.10.19 Bayer overweight Barclays Capital
17.10.19 Roche overweight Barclays Capital
09.10.19 Bayer overweight Barclays Capital
26.09.19 Bayer overweight Barclays Capital
13.09.19 AstraZeneca overweight Barclays Capital
09.09.19 Roche overweight Barclays Capital
06.09.19 AstraZeneca overweight Barclays Capital
16.08.19 Bayer overweight Barclays Capital
16.08.19 AstraZeneca overweight Barclays Capital
09.08.19 AstraZeneca overweight Barclays Capital
05.08.19 Roche overweight Barclays Capital
31.07.19 Bayer overweight Barclays Capital
30.07.19 Bayer overweight Barclays Capital
26.07.19 AstraZeneca overweight Barclays Capital
24.05.19 Bayer overweight Barclays Capital
24.05.19 Roche overweight Barclays Capital
24.05.19 AstraZeneca overweight Barclays Capital
14.05.19 Bayer overweight Barclays Capital